Jiang Wenbin
Reporting owner on Forms 3, 4 and 5, CIK 1872873.
Jiang Wenbin reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-20.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| CTKB · Cytek Biosciences, Inc.CIK 1831915 | director, officer (PRESIDENT AND CEO) | 1 | 2026-11-20 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| CTKB · Cytek Biosciences, Inc.Common Stock | 2026-11-18 | M exercised | +11,781 | 5,572,810 | Form 4 | |
| CTKB · Cytek Biosciences, Inc.Common Stock | 2026-11-18 | F withheld for tax | -4,636 | $5.92 | 5,568,174 | Form 4 |
| CTKB · Cytek Biosciences, Inc.Common Stock | 2026-11-18 | M exercised | +22,100 | 5,590,274 | Form 4 | |
| CTKB · Cytek Biosciences, Inc.Common Stock | 2026-11-18 | F withheld for tax | -8,697 | $5.92 | 5,581,577 | Form 4 |
| CTKB · Cytek Biosciences, Inc.Common Stock | 2026-11-18 | M exercised | +29,002 | 5,610,579 | Form 4 | |
| CTKB · Cytek Biosciences, Inc.Common Stock | 2026-11-18 | F withheld for tax | -11,413 | $5.92 | 5,599,166 | Form 4 |
| CTKB · Cytek Biosciences, Inc.Common Stock | 2026-11-18 | M exercised | +57,212 | 5,656,378 | Form 4 | |
| CTKB · Cytek Biosciences, Inc.Common Stock | 2026-11-18 | F withheld for tax | -22,513 | $5.92 | 5,633,865 | Form 4 |
| CTKB · Cytek Biosciences, Inc.Restricted Stock Units, derivative | 2026-11-18 | M exercised | -11,781 | $0 | 15,713 | Form 4 |
| CTKB · Cytek Biosciences, Inc.Restricted Stock Units, derivative | 2026-11-18 | M exercised | -22,100 | $0 | 117,873 | Form 4 |
| CTKB · Cytek Biosciences, Inc.Restricted Stock Units, derivative | 2026-11-18 | M exercised | -29,002 | $0 | 270,692 | Form 4 |
| CTKB · Cytek Biosciences, Inc.Restricted Stock Units, derivative | 2026-11-18 | M exercised | -57,212 | $0 | 762,842 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001872873-26-000007 | Cytek Biosciences, Inc. | 2026-11-20 |